Because HIF-1α activity in these tumors has been shown to enhance cellular motility and increased resistance to apoptosis and chemotherapy, it is reasonable to speculate that activation of the RAGE/S100A4 axis in CRC tumors favors tumor progression and chemoresistance through HIF-mediated mechanisms [202,203,204]. Here, HIF1A is linked to colorectal carcinoma.